These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16392393)

  • 1. [120 fatal brain complications. "Measles is not a harmless pediatric illness"].
    Lindlbauer-Eisenach U
    MMW Fortschr Med; 2005 Apr; 147(16):13. PubMed ID: 16392393
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vaccination deficits in Germany. Still fatalities caused by measles].
    MMW Fortschr Med; 2002 Apr; 144(14):54. PubMed ID: 12014285
    [No Abstract]   [Full Text] [Related]  

  • 3. Subacute sclerosing panencephalitis should be eliminated by measles vaccination.
    Liu WL; He ZX; Li F; He D; Ai R
    Hum Vaccin Immunother; 2017 Sep; 13(9):2038-2040. PubMed ID: 28750182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Encephalitic complications of measles in 1987].
    Celers J; Netter R
    Bull Acad Natl Med; 1989 Feb; 173(2):133-8; discussion 139. PubMed ID: 2765992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vaccine-preventable infectious disease kills half a million children annually.
    Katz SL
    J Infect Dis; 2005 Nov; 192(10):1679-80. PubMed ID: 16235162
    [No Abstract]   [Full Text] [Related]  

  • 6. "Melanie's measles" is deadly and causes permanent neurologic impairment.
    Hotez PJ
    Microbes Infect; 2018 Feb; 20(2):63-64. PubMed ID: 29126876
    [No Abstract]   [Full Text] [Related]  

  • 7. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA; Barakat SS; Abd El Fattah MM; Said ZN; El Metwally HA
    East Mediterr Health J; 2009; 15(1):85-93. PubMed ID: 19469430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Measles--atypical course and complications].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1991 Jun; 85(12):583-5. PubMed ID: 1681623
    [No Abstract]   [Full Text] [Related]  

  • 9. [Reasons for vaccinating against measles].
    Celers J; Netter R
    Bull Acad Natl Med; 1982 Jun; 166(6):801-7. PubMed ID: 6756595
    [No Abstract]   [Full Text] [Related]  

  • 10. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of potentially common adverse events associated with the first and second doses of measles-mumps-rubella vaccine.
    LeBaron CW; Bi D; Sullivan BJ; Beck C; Gargiullo P
    Pediatrics; 2006 Oct; 118(4):1422-30. PubMed ID: 17015532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    Shinefield HR; Black S; Kuter BJ
    J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complications of measles and antimeasles vaccination].
    Reinert P; Lemerle S; Kohout G; Bernaudin F
    Ann Pediatr (Paris); 1984 Jun; 31(6):477-80. PubMed ID: 6147112
    [No Abstract]   [Full Text] [Related]  

  • 15. [Measles infections at a Mozambique provincial hospital].
    Kotte W; Kotte S
    Kinderarztl Prax; 1988 Jul; 56(7):347-51. PubMed ID: 3262786
    [No Abstract]   [Full Text] [Related]  

  • 16. [Epidemics in vaccinated persons. Do adults need a mumps booster vaccination? (interview by Dr. Judith Neumaier)].
    Mankertz A
    MMW Fortschr Med; 2008 Jun; 150(23):7. PubMed ID: 18578069
    [No Abstract]   [Full Text] [Related]  

  • 17. MMR vaccination: new thought.
    Deshmukh V
    Indian Pediatr; 2006 Jun; 43(6):555-6. PubMed ID: 16820670
    [No Abstract]   [Full Text] [Related]  

  • 18. [Morbidity and mortality of infectious diseases determined mass vaccination in children under 5 ans in Bamako District].
    Diawara A; Sangho H; Sango H; Sacko M; Sow S; Toure K; Doumbo O; Simaga SY;
    Mali Med; 2006; 21(4):8-11. PubMed ID: 19437838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella.
    Ramet J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S49-55. PubMed ID: 18162247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life.
    Nair N; Gans H; Lew-Yasukawa L; Long-Wagar AC; Arvin A; Griffin DE
    J Infect Dis; 2007 Nov; 196(9):1339-45. PubMed ID: 17922398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.